Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection;Tratamiento de la psoriasis moderada-grave con etanercept en pacientes con infección crónica por el virus de la inmunodeficiencia humana

Actas Dermo-Sifiliograficas

Volumn 101, Issue SUPPL. 1, 2010, Pages 77-81

  Barco, D ^a   Puig, L ^a   Alomar, A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

AIDS; Anti TNF drugs; Etanercept; HIV; Psoriasis; Psoriatic arthritis; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; EFAVIRENZ; ETANERCEPT; ETRETIN; LAMIVUDINE; METHOTREXATE; VITAMIN D; ZIDOVUDINE; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PSORIASIS; PSORIASIS SEVERITY INDEX; PUVA; VIRUS LOAD; ANTAGONISTS AND INHIBITORS; COMPLICATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952536449     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(10)70013-2     Document Type: Article

References (14)

1. Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, et al. for the National Psoriasis Foundation. Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 (en prensa).
2. G. Linardaki, O. Katsarou, P. Ioannidou, A. Karafoulidou, and K. Boki Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection J Rheumatol 34 2007 1353 1355
3. R.S. Wallis, P. Kyambadde, J.L. Johnson, L. Horter, R. Kittle, and M. Pohle A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis AIDS 18 2004 257 264
4. U. Bartke, I. Venten, A. Kreuter, S. Gubbay, P. Altmeyer, and N.H. Brockmeyer Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab Br J Dermatol 150 2004 784 786
5. C. Bonifati, and F. Ameglio Cytokines in psoriasis Int J Dermatol 38 1999 241 251
6. L.H. Calabrese, N. Zein, and D. Vassilopoulos Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection Ann Rheum Dis 63 Suppl 2 2004 ii18 ii24
7. M. Mikhail, J.M. Weinberg, and B.L. Smith Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus Arch Dermatol 144 2008 453 456
8. Cepeda EJ, Williams FM, Ishimori ML, Weisman MH, Reveille JD. The use of anti-Tumor Necrosis Factor therapy in HIV positive individuals with rheumatic disease. Ann Rheum Dis. 2007 (en prensa).
9. B. Beltrán, P. Nos, G. Bastida, M. Iborra, M. Hoyos, and J. Ponce Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease Gut 55 2006 1670 1671
10. J. Sellam, B. Bouvard, C. Masson, M. Rousire, C. Villoutreix, and K. Lacombe Use of infliximab to treat psoriatic arthritis in HIV-positive patients Joint Bone Spine 74 2007 197 200
11. J. Filippi, P.M. Roger, S.M. Schneider, J. Durant, J.P. Breittmayer, S. Benzaken Groupe d'Etude Niois Polyvalent en Infectiologie (GENPI) Infliximab and human immunodeficiency virus infection: Viral load reduction and CD4+ T-cell loss related to apoptosis Arch Intern Med 166 2006 1783 1784
12. D.M. Aboulafia, D. Bundow, K. Wilske, and U.I. Ochs Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis Mayo Clin Proc 75 2000 1093 1098
13. P.T. Ting, and J.Y. Koo Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients Int J Dermatol 45 2006 689 692
14. G. Altomare, F. Ayala, E. Berardesca, S. Chimenti, A. Giannetti, and G. Girolomoni Etanercept provides a more physiological approach in the treatment of psoriasis Dermatol Ther 21 Suppl 2 2008 S1 S14